Skip to main content

Table 5 Blood hematology values

From: Effects of oral adenosine-5′-triphosphate supplementation on athletic performance, skeletal muscle hypertrophy and recovery in resistance-trained men

  Placebo ATP
  Before* SEM After SEM % Change Before SEM After SEM % Change p Value
WBC, x109/l 5.93 0.38 5.98 0.34 0.8 6.08 0.24 6.07 0.22 −0.1 0.67
RBC, x1012/l 5.16 0.10 5.19 0.09 0.7 5.13 0.04 5.07 0.05 −1.1 0.30
Hemoglobin, g/l 156 2.8 155 2.4 −1.0 157 2.2 156 2.0 −0.8 0.97
Hematocrit, l/l 0.46 0.01 0.46 0.01 0.0 0.47 0.01 0.46 0.01 −1.8 0.54
MCV, μm3 89.7 0.8 89.3 1.0 −0.5 90.6 0.8 89.7 0.8 −1.0 0.94
MCH, pg/cell 30.5 0.40 30.2 0.33 −1.1 30.4 0.32 30.5 0.44 0.3 0.42
MCHC, g/l 339 3.1 336 2.5 −0.9 334 3.9 340 4.4 2.1 0.16
RDW,% 13.4 0.1 13.4 0.1 0.0 13.1 0.1 13.2 0.1 0.8 0.62
Platelets, x109/l 247 9.0 236 9.1 −4.2 248 9.5 217 5.1 −12.5 0.64
Neutrophils,% 46.5 3.1 47.4 2.5 1.9 47.6 3.0 47.8 2.0 0.5 0.80
Lymphocytes,% 39.6 3.2 38.4 2.6 −3.0 39.0 2.8 38.8 1.7 −0.6 0.74
Monocytes,% 10.3 0.6 9.4 0.7 −8.7 9.3 0.5 9.6 0.6 3.0 0.57
Eosinophils,% 3.6 0.5 3.6 0.5 0.0 3.4 0.4 3.4 0.4 0.0 0.98
Basophils,% 0.6 0.2 0.7 0.2 16.7 0.4 0.2 0.4 0.2 −0.3 0.83
Neutrophils, x109/l 3.2 0.6 3.3 0.5 2.5 3.0 0.3 2.9 0.2 −2.3 0.27
Lymphocytes, x109/l 2.4 0.2 2.5 0.3 4.1 2.4 0.2 2.4 0.1 2.9 0.99
Monocytes, x109/l 0.67 0.08 0.62 0.08 −7.5 0.82 0.20 0.61 0.05 −25.6 0.62
Eosinophils, x109/l 0.21 0.02 0.21 0.02 0.0 0.21 0.03 0.22 0.03 4.4 0.32
Basophils, x109/l 0.02 0.01 0.01 0.01 −50.0 0.00 0.00 0.00 0.00 0.0 0.41
  1. *Values Before and After 12 weeks of either placebo or ATP (400 mg/d) administration.
  2. Standard error of the mean.
  3. P value for Trt*time effect, the model included data from weeks 4 and 8 (not shown).